Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Narcolepsy With Cataplexy: later-stage trial registry
1 of 3 indexed Narcolepsy With Cataplexy trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Narcolepsy With Cataplexy: 3 US clinical trials tracked, 1 recruiting.
Narcolepsy With Cataplexy is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Jazz Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition narcolepsy-with-cataplexy
OPEN 1 | RECR 33% | LATE 2 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Narcolepsy With Cataplexy lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Narcolepsy With Cataplexy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Narcolepsy With Cataplexy is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy
Takeda
NCT07363720
A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
Jazz Pharmaceuticals
NCT02221869
Narcolepsy Nightmare Study
Northwestern University
NCT05709873
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Narcolepsy With Cataplexy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Narcolepsy With Cataplexy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Narcolepsy With Cataplexy page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Narcolepsy With Cataplexy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Jazz Pharmaceuticals sponsors the most Narcolepsy With Cataplexy trials on record, review their full trial history before evaluating a specific study. See Jazz Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Narcolepsy With Cataplexy condition card totals 3 registered trials; most-linked intervention Xyrem; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.